Table 5 The most frequent CGH alterations in transformed diffuse large B-cell lymphoma in relation to the total number of alterations
From: Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma
Tumo no. | No. of alterations | −4q13–21 | +Xq25–26 | −8p22-pter | −9p23-pter | +7pter-q22 | +1q31–32 | +12q15 | +18q21 | −6q16–21 | +11q22 | −17p | +13q22 | −22q | +3q24–25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3 | 0 | ||||||||||||||
23:2 | 1 | −4q | |||||||||||||
24:2 | 2 | +Xq21-qter | |||||||||||||
4 | 2 | −8p22-pter | −9p23-pter | ||||||||||||
21:2 | 2 | +7 | +1q | ||||||||||||
27:2 | 2 | ||||||||||||||
7 | 3 | +7 | |||||||||||||
6 | 3 | +12pter-q22 | |||||||||||||
5 | 3 | +Xp11-q26 | −8p22-pter | −9p22-pter | |||||||||||
20:2 | 3 | ||||||||||||||
22:2 | 4 | −8p | +12q13–15 | +18q21 | |||||||||||
8 | 4 | −4q10–22 | +12pter-q22 | +18q | −6q14–21 | ||||||||||
17:2 | 4 | +X | +12q10–21 | ||||||||||||
30:5 | 4 | +X | +1q | −6q | |||||||||||
19:2 | 4 | +18pter-q21 | −6q15–23 | +11 | −17p | ||||||||||
25:2 | 4 | +X | +18q | +11 | |||||||||||
28:2 | 4 | +Xq25-qter | +7 | ||||||||||||
28:3 | 4 | +X | +7 | ||||||||||||
12:2 | 4 | +1q | |||||||||||||
15:2 | 5 | +18q12–22 | +11q14–22 | +13q12–22 | |||||||||||
12:1 | 5 | +1q | |||||||||||||
30:6 | 5 | +X | +1q | +12 | −6q | ||||||||||
27:3 | 5 | +X | +18pter-q21 | ||||||||||||
9 | 6 | −6q16-qter | +11q13–22 | ||||||||||||
26:2 | 7 | −9p | −17p | ||||||||||||
10 | 7 | −4q13–21 | −8p12-pter | +1q31-qter | +12p11–q21 | +11q22–23 | |||||||||
14:1 | 8 | +X | +7 | −6q | −17p | ||||||||||
16:2 | 8 | −4q21-qter | +Xq | −8p | −17p | ||||||||||
18:1 | 9 | +12q15–22 | |||||||||||||
11 | 9 | +7pter-q22 | |||||||||||||
13:2 | 10 | +X | +7 | +12p12-q21 | −6p21-q21 | −22q | |||||||||
13:1 | 11 | −4pter-q21 | +7 | +12p12-q21 | −6p21-q21 | ||||||||||
29:4 | 12 | +7pter-q31 | −6q14–25 | −17p | +13q22-qter | +3q25-qter | |||||||||
14:2 | 12 | +X | +7 | −6q | −17 | ||||||||||
14:3 | 12 | +X | +7 | −6q | −17 |
